Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)
Emma M. Kileel(Boston University), Steven Grinspoon(Massachusetts General Hospital), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Nwora Lance Okeke(Duke University), Janet Lo(Harvard University), Pamela S. Douglas(Duke University), Sara H Bares(Nebraska Medical Center), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Jhoanna C. Roa(Cancer Research And Biostatistics), Estebán Martínez(Instituto de Salud Carlos III), Princy Kumar(Georgetown University), Kathleen V. Fitch(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Esaú João(Hospital Federal dos Servidores do Estado), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Daniel Berrner(San Francisco General Hospital), Markella V. Zanni(Harvard University), Marek Smieja(Hamilton Regional Laboratory Medicine Program), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 8
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k